GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (WBO:TKD) » Definitions » Cyclically Adjusted PB Ratio

Takeda Pharmaceutical Co (WBO:TKD) Cyclically Adjusted PB Ratio : 1.17 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Takeda Pharmaceutical Co's current share price is €24.37. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €20.89. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.17.

The historical rank and industry rank for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

WBO:TKD' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 1.39   Max: 2.42
Current: 1.22

During the past years, Takeda Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 2.42. The lowest was 1.03. And the median was 1.39.

WBO:TKD's Cyclically Adjusted PB Ratio is ranked better than
66.76% of 692 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs WBO:TKD: 1.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was €28.466. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €20.89 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.40 1.19 1.37 1.24

Takeda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.40 1.41 1.21 1.24

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=24.37/20.89
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=28.466/107.2000*107.2000
=28.466

Current CPI (Mar. 2024) = 107.2000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 21.818 98.000 23.866
201409 22.543 98.500 24.534
201412 21.550 97.900 23.597
201503 20.870 97.900 22.853
201506 19.840 98.400 21.614
201509 19.994 98.500 21.760
201512 20.149 98.100 22.018
201603 19.776 97.900 21.655
201606 19.499 98.100 21.308
201609 20.321 98.000 22.229
201612 20.665 98.400 22.513
201703 20.088 98.100 21.951
201706 20.696 98.500 22.524
201709 20.222 98.800 21.941
201712 20.242 99.400 21.830
201803 19.551 99.200 21.128
201806 20.341 99.200 21.981
201809 21.217 99.900 22.767
201812 20.442 99.700 21.980
201903 26.539 99.700 28.535
201906 25.653 99.800 27.555
201909 26.373 100.100 28.244
201912 25.801 100.500 27.521
202003 25.487 100.300 27.240
202006 24.750 99.900 26.559
202009 23.979 99.900 25.731
202012 23.481 99.300 25.349
202103 25.571 99.900 27.440
202106 25.172 99.500 27.120
202109 26.118 100.100 27.971
202112 26.613 100.100 28.501
202203 27.903 101.100 29.587
202206 28.852 101.800 30.382
202209 30.440 103.100 31.651
202212 27.799 104.100 28.627
202303 28.562 104.400 29.328
202306 29.070 105.200 29.623
202309 28.562 106.200 28.831
202312 27.368 106.800 27.471
202403 28.466 107.200 28.466

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Takeda Pharmaceutical Co  (WBO:TKD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (WBO:TKD) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (WBO:TKD) Headlines

No Headlines